(M2 PressWIRE Via Acquire Media NewsEdge) BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Wednesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Wednesday there were 3592 companies with "abnormal" market making, 1590 companies with positive Friction Factors and 4421 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Wednesday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. Novogen Ltd (NASDAQ:NVGN), Cornerstone Therapeutics Inc (NASDAQ:CRTX), China Housing & Land Development Inc (NASDAQ:CHLN), Chelsea Therapeutics International Ltd (NASDAQ:CHTP), TUCOWS INC (AMEX:TCX), Meru Networks Inc (NASDAQ:MERU). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
Market Maker Friction Factor is shown in the chart below:
Symbol Change Percent Buy Volume Buy %% Sell Volume Sell %% Net Volume Friction
NVGN $1.680 25.97% 1,596,110 49.32% 1,592,894 49.22% 3,216 19
CRTX $1.110 20.18% 153,784 56.21% 116,084 42.43% 37,700 340
CHLN $0.330 24.81% 137,083 76.84% 41,313 23.16% 95,770 2,902
CHTP $1.150 150.82% 16,357,978 52.84% 14,596,240 47.15% 1,761,738 15,319
TCX $0.210 13.38% 155,742 30.81% 149,989 29.67% 5,753 274
MERU $0.680 19.88% 753,558 53.09% 664,131 46.79% 89,427 1,315
Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net buy volumes (buy volume, sell volume) and low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.
For example, the chart above shows NVGN with a dollar gain Wednesday of $1.68000 and a Friction Factor of 19 shares. That means that it only took 19 more shares of buying than selling to move NVGN higher by one penny. The Market Makers are currently allowing the stock to rise quickly (low friction). The combination of low friction and positive market direction can drive prices higher much faster than normal.
Novogen Ltd (NASDAQ:NVGN) - Novogen Limited, a biotechnology company, engages in the research and development of prescription drugs. Its products include ME-143, an analogue of Phenoxodiol that is Phase I clinical trials; NV-128, a novel mitochondrial inhibitor, which is in preclinical trials targeting a range of cancers; ME-344, which is in Phase I clinical trials for the treatment of tumors; and GLYC-101 Gel to stimulate and modulate the natural cascade of wound healing activities in several cell populations. The company s products also comprise NV-143, an active against melanoma cells; NV-04 to treat cardiovascular diseases; NV-27, an oral agent to prevent arterial restenosis; NV-07 for the protection of mice against UV-induced inflammatory changes in the skin, and against UV-induced skin immune suppression; flavonoid anti-inflammatory molecules for general pain relief; and NV-52, a synthetic anti-inflammatory drug. It operates primarily in Australia, North America, Europe, and Asia. The company was founded in 1992 and is headquartered in North Ryde, Australia..
Cornerstone Therapeutics Inc (NASDAQ:CRTX) - Cornerstone Therapeutics Inc., a specialty pharmaceutical company, engages in the acquisition, development, and commercialization of prescription pharmaceutical drugs for the hospital, niche respiratory, and related specialty markets. The company offers CUROSURF, a natural lung surfactant used for the treatment of respiratory distress syndrome in premature infants; and ZYFLO CR and ZYFLO, which are leukotriene synthesis inhibitor drugs used for the prevention and chronic treatment of asthma in adults and children. The company s product pipeline also includes CRTX 080, a vasopressin receptor 2 antagonist lixivaptan used for the treatment of hyponatremia; CRTX 073, an anti-asthma product candidate used for the treatment of asthma; and CRTX 067, a cough/cold product candidate for the treatment of cough and cold. It serves drug wholesalers, retail drug stores, mass merchandisers, and grocery store pharmacies in the United States. The company was formerly known as Critical Therapeutics, Inc. and changed its name to Cornerstone Therapeutics Inc. as a result of its merger with Cornerstone BioPharma Holdings, Inc. in October 2008. Cornerstone Therapeutics Inc. was founded in 2000 and is headquartered in Cary, North Carolina. Cornerstone Therapeutics Inc operates as a subsidiary of Chiesi Farmaceutici S.p.A.
China Housing & Land Development Inc (NASDAQ:CHLN) - China Housing & Land Development, Inc., through its subsidiaries, engages in the acquisition, development, management, and sale of commercial and residential real estate properties primarily in Xi an, the People s Republic of China. It focuses on developing residential properties in tier-II and tier-III cities in western China for middle class families. The company s projects include multi-family residential and commercial properties, as well as land development activities. Its customers primarily comprise first time home buyers and first time up-graders. The company was founded in 1999 and is headquartered in Xi an, the People s Republic of China..
Chelsea Therapeutics International Ltd (NASDAQ:CHTP) - Chelsea Therapeutics International, Ltd., a development-stage pharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products. It is primarily developing Northera (droxidopa), a novel therapeutic agent for the treatment of symptomatic neurogenic orthostatic hypotension (Neurogenic OH) in patients with primary autonomic failure, dopamine- -hydroxylase, deficiency, and non-diabetic autonomic neuropathy. The company is also evaluating the therapeutic applications of droxidopa in reducing the frequency of falls in patients with Neurogenic OH associated with Parkinson s disease, as well as other potentially norepinephrine related conditions and diseases, including intradialytic hypotension, fibromyalgia, and adult attention deficit hyperactivity disorder. In addition, it engages in developing a portfolio of metabolically inert antifolates for the treatment of rheumatoid arthritis and for the treatment of multiple other autoimmune disorders, including psoriasis, Crohn s disease, uveitis, ankylosing spondylitis, inflammatory bowel disease, cancer, and other immunological disorders. Chelsea Therapeutics International, Ltd. was founded in 2002 and is headquartered in Charlotte, North Carolina..
TUCOWS INC (AMEX:TCX) - Tucows Inc. distributes Internet services worldwide. The company offers domain name registration, and security and identity products through digital certificates, email, and mobile telephony services. It provides OpenSRS, a wholesale service, which manages domain names, mailboxes, and digital certificates through a network of approximately 11,000 Web hosts, Internet service providers (ISPs), and other resellers; Platypus, a billing service that provides ISPs with an industry-specific solution for billing, service provisioning, and customer account management; and Hover, a retail service, which offers domain names, mailboxes, and digital certificates management services for consumers and small businesses. In addition, the company offers YummyNames that manages various domain names with a portfolio of approximately 42,000 domains; and Butterscotch, a content service, which operates butterscotch.com and tucows.com advertising-supported Websites that provide content in the form of approximately 4,000 videos and 385,000 software and mobile listings, and articles. The company was formerly known as Infonautics, Inc. and changed its name to Tucows Inc. in August 2001. Tucows Inc. was founded in 1992 and is headquartered in Toronto, Canada..
Meru Networks Inc (NASDAQ:MERU) - Meru Networks, Inc., together with its subsidiaries, provides wireless local area network (LAN) solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It offers a virtualized wireless LAN solution based on its System Director Operating System, which runs on its controllers and access points to enable enterprises to deliver business-critical applications over wireless networks. The company s System Director Operating System provides centralized coordination and control of various access points on the network; controllers synchronize access points to optimize the user experience and manage traffic on the network; and Wi-Fi certified access points to provide network connectivity for wireless devices. It also offers Meru Networks E(z)RF application suite comprising E(z)RF Network Manager, E(z)RF Service Assurance Manager, E(z)RF Location Manager, E(z)RF OnTheGo, Spectrum Manager, and wired and wireless management solutions, which enable enterprises to configure, monitor, troubleshoot, secure, and operate virtualized wireless LAN solution. In addition, the company provides Identity Manager that simplifies enterprise network access and identity management; Wireless Intrusion Prevention System to recognize and mitigate threats; Compliance Manager to reduce the risk of security breach by protecting customer and employee personal information by extending security to the wireless network; AirFirewall to intercept and block unwanted communications as they transmit over the air, stopping them before they reach the network; and Security Gateway SG1000 to meet the demands of the Federal Information Processing Standard, 140-2 Level 3 security required by federal government agencies and other security-conscious organizations. It serves the education, healthcare, hospitality, manufacturing, retail, technology, finance, government, telecom, transportation, and utility markets. The company was founded in 2002 and is headquartered in Sunnyvale, California..
BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO
INVESTMENTS & TRADING
SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.
((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to firstname.lastname@example.org)).